178 related articles for article (PubMed ID: 24633957)
1. Co-crystallization with nicotinamide in two conformations lowers energy but expands volume.
Zhang SW; Kendrick J; Leusen FJJ; Yu L
J Pharm Sci; 2014 Sep; 103(9):2896-2903. PubMed ID: 24633957
[TBL] [Abstract][Full Text] [Related]
2. Cocrystals of nicotinamide and (R)-mandelic acid in many ratios with anomalous formation properties.
Zhang SW; Harasimowicz MT; de Villiers MM; Yu L
J Am Chem Soc; 2013 Dec; 135(50):18981-9. PubMed ID: 24215608
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
[TBL] [Abstract][Full Text] [Related]
4. Physical stability enhancement of theophylline via cocrystallization.
Trask AV; Motherwell WD; Jones W
Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188
[TBL] [Abstract][Full Text] [Related]
5. Terahertz spectroscopic characterizations and DFT calculations of carbamazepine cocrystals with nicotinamide, saccharin and fumaric acid.
Zhou Q; Shen Y; Li Y; Xu L; Cai Y; Deng X
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Aug; 236():118346. PubMed ID: 32302958
[TBL] [Abstract][Full Text] [Related]
6. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
Lin HL; Zhang GC; Huang YT; Lin SY
J Pharm Sci; 2014 Aug; 103(8):2386-95. PubMed ID: 24942554
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and molecular modeling of a pharmaceutical co-crystal: (2-chloro-4-nitrobenzoic acid):(nicotinamide).
Lemmerer A; Esterhuysen C; Bernstein J
J Pharm Sci; 2010 Sep; 99(9):4054-71. PubMed ID: 20574994
[TBL] [Abstract][Full Text] [Related]
8. Impact of polymeric excipient on cocrystal formation via hot-melt extrusion and subsequent downstream processing.
Karimi-Jafari M; Ziaee A; Iqbal J; O'Reilly E; Croker D; Walker G
Int J Pharm; 2019 Jul; 566():745-755. PubMed ID: 31212053
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of electrospray deposition for rapid screening of the cocrystal formation and single step, continuous production of pharmaceutical nanococrystals.
Emami S; Siahi-Shadbad M; Barzegar-Jalali M; Adibkia K
Drug Dev Ind Pharm; 2018 Jun; 44(6):1034-1047. PubMed ID: 29347850
[TBL] [Abstract][Full Text] [Related]
10. Cocrystal architecture and properties: design and building of chiral and racemic structures by solid-solid reactions.
Friscić T; Jones W
Faraday Discuss; 2007; 136():167-78; discussion 213-29. PubMed ID: 17955809
[TBL] [Abstract][Full Text] [Related]
11. Terahertz spectroscopy and computational investigation of the flufenamic acid/nicotinamide cocrystal.
Delaney SP; Korter TM
J Phys Chem A; 2015 Apr; 119(13):3269-76. PubMed ID: 25787318
[TBL] [Abstract][Full Text] [Related]
12. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
13. The cocrystal nicotinamide-succinic acid (2/1).
Thompson LJ; Voguri RS; Cowell A; Male L; Tremayne M
Acta Crystallogr C; 2010 Aug; 66(Pt 8):o421-4. PubMed ID: 20679721
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism and stability of ibuprofen/nicotinamide cocrystal: The effect of the crystalline synthesis method.
Guerain M; Guinet Y; Correia NT; Paccou L; Danède F; Hédoux A
Int J Pharm; 2020 Jun; 584():119454. PubMed ID: 32464230
[TBL] [Abstract][Full Text] [Related]
15. The nature of interactions in nicotinamide crystal.
Misiaszek T; Czyżnikowska Ż
J Mol Graph Model; 2014 Jun; 51():73-8. PubMed ID: 24863341
[TBL] [Abstract][Full Text] [Related]
16. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
17. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
Boksa K; Otte A; Pinal R
J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
[TBL] [Abstract][Full Text] [Related]
18. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
19. Formation of Prenylated Chalcone Xanthohumol Cocrystals: Single Crystal X-Ray Diffraction, Vibrational Spectroscopic Study Coupled with Multivariate Analysis.
Budziak I; Arczewska M; Kamiński DM
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766540
[TBL] [Abstract][Full Text] [Related]
20. Terahertz spectroscopic characterizations and DFT calculations of indomethacin cocrystals with nicotinamide and saccharin.
Xu L; Li Y; Jing P; Xu G; Zhou Q; Cai Y; Deng X
Spectrochim Acta A Mol Biomol Spectrosc; 2021 Mar; 249():119309. PubMed ID: 33341744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
